CD8A and neoplasm: Although targeting a combination of the other TNFR members may achieve a similar goal, exploiting the downstream effects of OX-40 signaling could potentially achieve a favorable tumor microenvironment rich in effector cytotoxic CD8+ T-cells and depleted in Tregs.